Related references
Note: Only part of the references are listed.Protease inhibitor-based antiretroviral therapy in pregnancy: effects on hormones, placenta, and decidua
Caroline E. Dunk et al.
LANCET HIV (2022)
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Shahin Lockman et al.
LANCET (2021)
Maternal HIV infection is associated with distinct systemic cytokine profiles throughout pregnancy in South African women
Charlene Akoto et al.
SCIENTIFIC REPORTS (2021)
Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial
Joan T. Price et al.
LANCET HIV (2021)
Children Exposed or Unexposed to Human Immunodeficiency Virus: Weight, Height, and Body Mass Index During the First 5 Years of Life-A Danish Nationwide Cohort
Ellen Moseholm et al.
CLINICAL INFECTIOUS DISEASES (2020)
Investigation of factors associated with spontaneous preterm birth in pregnant women living with HIV
Arianne Y. K. Albert et al.
AIDS (2020)
Changes in the Vα7.2+CD161++ MAIT cell compartment in early pregnancy are associated with preterm birth in HIV-positive women
Krithi Ravi et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2020)
Mid-trimester cervical length not associated with HIV status among pregnant women in Botswana
Ingrid Liff et al.
PLOS ONE (2020)
Adverse perinatal outcomes associated with antiretroviral therapy regimens: systematic review and network meta-analysis
Chrystelle O. O. Tshivuila-Matala et al.
AIDS (2020)
Does HIV infection modify the relationship between pre-pregnancy body mass index and adverse birth outcomes?
Angela M. Bengtson et al.
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2020)
Innate lymphoid cells are reduced in pregnant HIV positive women and are associated with preterm birth
Charlene Akoto et al.
SCIENTIFIC REPORTS (2020)
Initiation of Antiretroviral Therapy Before Pregnancy Reduces the Risk of Infection-related Hospitalization in Human Immunodeficiency Virus-exposed Uninfected Infants Born in a High-income Country
Tessa Goetghebuer et al.
CLINICAL INFECTIOUS DISEASES (2019)
Pregnancy Outcomes in the Era of Universal Antiretroviral Treatment in Sub-Saharan Africa (POISE Study)
Sufia Dadabhai et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2019)
Cardiac and mitochondrial function in HIV-uninfected fetuses exposed to antiretroviral treatment
Laura Garcia-Otero et al.
PLOS ONE (2019)
Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa
Wahyu B. Santosa et al.
AIDS (2019)
Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana
Rebecca Zash et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Birth outcomes following antiretroviral exposure during pregnancy: Initial results from a pregnancy exposure registry in South Africa
Ushma C. Mehta et al.
SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE (2019)
Pregnancy outcome among HIV-infected women on different antiretroviral therapies in Ethiopia: a cohort study
Yohannes Ejigu et al.
BMJ OPEN (2019)
Compromised Growth Among HIV-exposed Uninfected Compared With Unexposed Children in Nigeria
Jibreel Jumare et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2019)
Combination Antiretroviral Therapy and Hypertensive Disorders of Pregnancy
Michele K. Saums et al.
OBSTETRICS AND GYNECOLOGY (2019)
Comparison of 6-week PMTCT outcomes for HIV-exposed and HIV-unexposed infants in the era of lifelong ART: Results from an observational prospective cohort study
Appolinaire Tiam et al.
PLOS ONE (2019)
Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis
Saifon Chawanpaiboon et al.
LANCET GLOBAL HEALTH (2019)
Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age
Ingrid J. M. Snijdewind et al.
PLOS ONE (2018)
Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
Rebecca Zash et al.
LANCET GLOBAL HEALTH (2018)
Methods of gestational age assessment influence the observed association between antiretroviral therapy exposure, preterm delivery, and small-for-gestational age infants: a prospective study in Cape Town, South Africa
Thokozile Rosemary Malaba et al.
ANNALS OF EPIDEMIOLOGY (2018)
Elevated Levels of Estradiol in Human Immunodeficiency Virus-Infected Pregnant Women on Protease Inhibitor-Based Regimens
Kayode A. Balogun et al.
CLINICAL INFECTIOUS DISEASES (2018)
Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women
Thokozile R. Malaba et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
PMTCT Option B plus Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi
Maganizo B. Chagomerana et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis, and Adverse Perinatal Outcomes in HIV Pregnancies Under Antiretroviral Treatment Containing Zidovudine
Sandra Hernandez et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Maternal and Obstetric Complications among HIV-infected Women Treated with Highly Active Antiretroviral Treatment at a Regional Hospital in Durban, South Africa
H. M. Sebitloane et al.
NIGERIAN JOURNAL OF CLINICAL PRACTICE (2017)
Methods for Estimating the Due Date
Christian M. Pettker et al.
OBSTETRICS AND GYNECOLOGY (2017)
Option B plus for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda
Eva M. Rempis et al.
BMC PREGNANCY AND CHILDBIRTH (2017)
Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets
Anne C. C. Lee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets
Anne C. C. Lee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Preconception ART and preterm birth: real effect or selection bias?
Jeffrey S A Stringer et al.
Lancet HIV (2017)
Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis
Olalekan A. Uthman et al.
LANCET HIV (2017)
In Utero ART Exposure and Birth and Early Growth Outcomes Among HIV-Exposed Uninfected Infants Attending Immunization Services: Results From National PMTCT Surveillance, South Africa
Vundli Ramokolo et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study
Nan Li et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Antiretroviral Therapy and Adverse Pregnancy Outcome: The Elephant in the Room?
Lynne M. Mofenson
JOURNAL OF INFECTIOUS DISEASES (2016)
Predictors and outcomes of low birth weight in Lusaka, Zambia
Carla J. Chibwesha et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2016)
Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa
Theron Moodley et al.
BMC PREGNANCY AND CHILDBIRTH (2016)
Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis
Chrystelle O. O. Wedi et al.
LANCET HIV (2016)
Antiretroviral Therapy Use During Pregnancy and the Risk of Small for Gestational Age Birth in a Medicaid Population
Kelesitse Phiri et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?
Fatima Kakkar et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2015)
The Distribution of Clinical Phenotypes of Preterm Birth Syndrome Implications for Prevention
Fernando C. Barros et al.
JAMA PEDIATRICS (2015)
HIV Protease Inhibitor Use During Pregnancy Is Associated With Decreased Progesterone Levels, Suggesting a Potential Mechanism Contributing to Fetal Growth Restriction
Eszter Papp et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission
C-E S. Short et al.
HIV MEDICINE (2014)
Risk Factors for Preterm Birth Among HIV-Infected Pregnant Ugandan Women Randomized to Lopinavir/Ritonavir- or Efavirenz-Based Antiretroviral Therapy
Catherine A. Koss et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project
Jose Villar et al.
LANCET (2014)
Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine
Heather Bailey et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2013)
HIV-associated chronic immune activation
Mirko Paiardini et al.
IMMUNOLOGICAL REVIEWS (2013)
Combination Antiretroviral Use and Preterm Birth
D. Heather Watts et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Hematological Changes in Women and Infants Exposed to an AZT-Containing Regimen for Prevention of Mother-to-Child-Transmission of HIV in Tanzania
Judith Ziske et al.
PLOS ONE (2013)
National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010
Anne C. C. Lee et al.
LANCET GLOBAL HEALTH (2013)
Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART
Marta Lopez et al.
AIDS (2012)
Highly Active Antiretroviral Therapy and Adverse Birth Outcomes Among HIV-Infected Women in Botswana
Jennifer Y. Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications
Hannah Blencowe et al.
LANCET (2012)
Risk of Preeclampsia in HIV-Positive Pregnant Women Receiving HAART: A Matched Cohort Study
Talar Boyajian et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2012)
Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes
Maria C. Marazzi et al.
AIDS (2011)
Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data
C. Rudin et al.
HIV MEDICINE (2011)
Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During Pregnancy
Kathleen M. Powis et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study
Karin van der Merwe et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2011)
Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria
Biodun N. Olagbuji et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2010)
Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe
C. L. Townsend et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2010)
Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy
Sina Haeri et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Lack of Effect on Prematurity, Birth Weight, and Infant Growth from Exposure to Protease Inhibitors In Utero and After Birth
Ana Carceller et al.
PHARMACOTHERAPY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric spectrum of HIV disease, 1989-2004
Joann Schulte et al.
PEDIATRICS (2007)
Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis
Athena P. Kourtis et al.
AIDS (2007)
The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery
K. Boer et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2007)
Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003
Covadonga Marti et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2007)
Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?
AM Cotter et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Neonatal survival 1 - 4 million neonatal deaths: When? where? why?
JE Lawn et al.
LANCET (2005)
Antiretroviral therapy during pregnancy and the risk of an adverse outcome
RE Tuomala et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
